openPR Logo
Press release

Investigation announced for Investors in shares of AdaptHealth Corp. (NASDAQ: AHCO)

04-19-2021 08:30 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in AdaptHealth Corp. (NASDAQ: AHCO) shares over potential securities laws violations by AdaptHealth

An investigation for investors in AdaptHealth Corp. (NASDAQ: AHCO) shares over potential securities laws violations by AdaptHealth

An investigation was announced over potential securities laws violations by AdaptHealth Corp. in connection with certain financial statements.

Investors who purchased shares of AdaptHealth Corp. (NASDAQ: AHCO), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by AdaptHealth Corp. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Plymouth Meeting, PA based AdaptHealth Corp., together with its subsidiaries, provides home healthcare equipment, medical supplies, and home and related services in the United States. On April 13, 2021, AdaptHealth announced that the Company "has learned that authorities in Denmark have formally charged Co-Chief Executive Officer Luke McGee with alleged tax fraud arising from certain past private activity. The alleged personal conduct occurred between March 2014 and August 2015 and had no connection to AdaptHealth's business." AdaptHealth further stated that it "has placed Mr. McGee on unpaid leave from his roles as Co-CEO and a Director of the Company while this matter is pending."

Shares of AdaptHealth Corp. (NASDAQ: AHCO) declined from $38.84 per share on April 6, 2021, to as low as $28.20 per share on April 14, 2021.

Those who purchased shares of AdaptHealth Corp. (NASDAQ: AHCO) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of AdaptHealth Corp. (NASDAQ: AHCO) here

News-ID: 2272311 • Views: 733

More Releases from Shareholders Foundation

Investigation announced for Investors in shares of Laboratory Corporation of Ame …
An investigation was announced concerning potential securities laws violations by Laboratory Corporation of America Holdings in connection with certain financial statements. Investors who purchased shares of Laboratory Corporation of America Holdings (NYSE: LH), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Laboratory Corporation of America Holdings regarding its business,
Investigation announced for Investors in Aytu BioScience, Inc. (NASDAQ: AYTU)
An investigation on behalf of investors of Aytu BioScience, Inc. (NASDAQ: AYTU) shares over potential securities laws violations by Aytu BioScience, Inc. (NASDAQ: AYTU and certain of its directors and officers in connection with certain financial statements was announced. Investors who purchased shares of Aytu BioScience, Inc. (NASDAQ: AYTU), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm
DraftKings Inc. (NASDAQ: DKNG) Investor Alert: Update in Lawsuit
The Shareholders Foundation announced an update in the lawsuit that is pending for certain investors in shares of DraftKings Inc. (NASDAQ: DKNG). If you purchased shares of DraftKings Inc. (NASDAQ: DKNG) prior to December 2019 and continue to hold any of those shares, you have also certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On July 2, 2021, a lawsuit was filed
Lawsuit filed for Investors in shares of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP …
An investor, who purchased shares of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP), filed a lawsuit over alleged violations of Federal Securities Laws by NRx Pharmaceuticals, Inc. Investors who purchased shares of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) have certain options and for certain investors are short and strict deadlines running. Deadline: March 21, 2022. NASDAQ: NRXP investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Wilmington, DE based NRX

All 5 Releases


More Releases for AdaptHealth

Respiratory Devices Market Size Estimation by Top Manufacturer, Growth Rate by R …
Respiratory system is a biological system consisting of specific organs and structures used for gas (CO2 and O2) exchange. If there is a problem in functioning of the respiratory system then the condition may lead to Chronic Obstructive Pulmonary Disease, emphysema, bronchiectasis, asthma, chronic bronchitis or pulmonary fibrosis and others. To treat such conditions several respiratory devices are required, such as positive expiratory pressure, high frequency chest wall oscillation, oral
Respiratory Devices Market Report 2020 Leading Industrialist Growth Forecast Ana …
Respiratory system is a biological system consisting of specific organs and structures used for gas (CO2 and O2) exchange. If there is a problem in functioning of the respiratory system then the condition may lead to Chronic Obstructive Pulmonary Disease, emphysema, bronchiectasis, asthma, chronic bronchitis or pulmonary fibrosis and others. To treat such conditions several respiratory devices are required, such as positive expiratory pressure, high frequency chest wall oscillation, oral
Respiratory Devices Market Insights By Top Players Masimo Corporation, Teleflex …
Respiratory devices are medical devices that are used to assist a patient suffering from breathing problems. These devices are used in management and treatment of disorders such as fibrosis, asthma, chronic obstructive pulmonary disease (COPD), and acute respiratory distress syndrome (ARDS). The global respiratory devices market is estimated to account for US$ 16,878.0 Mn in terms of value in 2019 and is expected to reach US$ 34,178.1 Mn by the end